105 related articles for article (PubMed ID: 31914559)
21. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
22. [Application on the quantitative perfusion parameters of dynamic contrast-enhanced MRI in the pathological subtype of uterine leiomyoma].
Zheng J; Zhao ZH; Yang JF; Zhao L; Yang LM; Hu HJ
Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1155-1159. PubMed ID: 28427122
[No Abstract] [Full Text] [Related]
23. [Quantitatively evaluating the evolution of the tumor perfusion in A549 lung adenocarcinoma transplantation model induced by antiangiogenic treatment].
Xiong Z; Deng P; Hu C; Liu J; Yang H; Zhou J; Wang Y; Zhou H; Zhu Z
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(4):306-10. PubMed ID: 26879795
[TBL] [Abstract][Full Text] [Related]
24. Response-Derived Input Function Estimation for Dynamic Contrast-Enhanced MRI Demonstrated by Anti-DLL4 Treatment in a Murine U87 Xenograft Model.
Silva MD; Yerby B; Moriguchi J; Gomez A; Toni Jun H; Coxon A; Ungersma SE
Mol Imaging Biol; 2017 Oct; 19(5):673-682. PubMed ID: 28265853
[TBL] [Abstract][Full Text] [Related]
25. Cluster analysis of DCE-MRI data identifies regional tracer-kinetic changes after tumor treatment with high intensity focused ultrasound.
Jacobs I; Hectors SJ; Schabel MC; Grüll H; Strijkers GJ; Nicolay K
NMR Biomed; 2015 Nov; 28(11):1443-54. PubMed ID: 26390040
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI.
Liang J; Dai W; Li Z; Liang X; Xiao M; Xie C; Li X
BMC Cancer; 2022 Oct; 22(1):1033. PubMed ID: 36192709
[TBL] [Abstract][Full Text] [Related]
27. DCE-MRI of Sunitinib-Induced Changes in Tumor Microvasculature and Hypoxia: A Study of Pancreatic Ductal Adenocarcinoma Xenografts.
Wegner CS; Hauge A; Simonsen TG; Gaustad JV; Andersen LMK; Rofstad EK
Neoplasia; 2018 Jul; 20(7):734-744. PubMed ID: 29886124
[TBL] [Abstract][Full Text] [Related]
28. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
[TBL] [Abstract][Full Text] [Related]
29. Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI.
Hectors SJ; Jacobs I; Lok J; Peters J; Bussink J; Hoeben FJ; Keizer HM; Janssen HM; Nicolay K; Schabel MC; Strijkers GJ
Cancer Res; 2018 Mar; 78(6):1561-1570. PubMed ID: 29317433
[TBL] [Abstract][Full Text] [Related]
30. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B
NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069
[TBL] [Abstract][Full Text] [Related]
31. New Cluster Analysis Method for Quantitative Dynamic Contrast-Enhanced MRI Assessing Tumor Heterogeneity Induced by a Tumor-Microenvironmental Ameliorator (E7130) Treatment to a Breast Cancer Mouse Model.
Makihara K; Yamaguchi M; Ito K; Sakaguchi K; Hori Y; Semba T; Funahashi Y; Fujii H; Terada Y
J Magn Reson Imaging; 2022 Dec; 56(6):1820-1831. PubMed ID: 35524730
[TBL] [Abstract][Full Text] [Related]
32. A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer.
Cai W; Li F; Wang J; Du H; Wang X; Zhang J; Fang J; Jiang X
NMR Biomed; 2014 Jul; 27(7):817-25. PubMed ID: 24809332
[TBL] [Abstract][Full Text] [Related]
33. Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS.
Jensen LR; Huuse EM; Bathen TF; Goa PE; Bofin AM; Pedersen TB; Lundgren S; Gribbestad IS
NMR Biomed; 2010 Jan; 23(1):56-65. PubMed ID: 19650073
[TBL] [Abstract][Full Text] [Related]
34. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
[TBL] [Abstract][Full Text] [Related]
35. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
[TBL] [Abstract][Full Text] [Related]
36. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.
Wegner CS; Hauge A; Gaustad JV; Andersen LMK; Simonsen TG; Galappathi K; Rofstad EK
Acta Oncol; 2017 Dec; 56(12):1754-1762. PubMed ID: 28661213
[TBL] [Abstract][Full Text] [Related]
37. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
38. Detection of Treatment Success after Photodynamic Therapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Schreurs TJL; Jacobs I; Nicolay K; Prompers JJ; Strijkers GJ
Theranostics; 2017; 7(19):4643-4657. PubMed ID: 29187893
[TBL] [Abstract][Full Text] [Related]
39. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
Malamas AS; Jin E; Zhang Q; Haaga J; Lu ZR
Pharm Res; 2015 Sep; 32(9):3029-43. PubMed ID: 25840948
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.
Ceelen W; Smeets P; Backes W; Van Damme N; Boterberg T; Demetter P; Bouckenooghe I; De Visschere M; Peeters M; Pattyn P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1188-96. PubMed ID: 16457965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]